Vaginolysin drives epithelial ultrastructural responses to gardnerella vaginalis

Infection and Immunity

Volumn 81, Issue 12, 2013, Pages 4544-4550

  Randis, Tara M ^a   Zaklama, Joanne ^a   LaRocca, Timothy J ^a   Los, Ferdinand C O ^a   Lewis, Emma L ^a   Desai, Purnahamsi ^a   Rampersaud, Ryan ^a   Amaral, Fábio E ^a   Ratner, Adam J ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLYSIN; UNCLASSIFIED DRUG; VAGINOLYSIN;

ANIMAL CELL; ARTICLE; BACTERIUM CULTURE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GARDNERELLA INFECTION; GARDNERELLA VAGINALIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX EPITHELIUM; VAGINA EPITHELIUM;

ANIMALS; ANTIGENS, CD59; BACTERIAL PROTEINS; BACTERIAL TOXINS; BETA-CYCLODEXTRINS; CELL SURFACE EXTENSIONS; CERVIX UTERI; CHO CELLS; CRICETULUS; EPITHELIAL CELLS; FEMALE; GARDNERELLA VAGINALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HELA CELLS; HUMANS; SIGNAL TRANSDUCTION; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84890150824     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00627-13     Document Type: Article

References (43)

1. Hotze EM, Le HM, Sieber JR, Bruxvoort C, McInerney MJ, Tweten RK. 2013. Identification and characterization of the first cholesteroldependent cytolysins from Gram-negative bacteria. Infect. Immun. 81:216-225.
2. Gaillard JL, Berche P, Sansonetti P. 1986. Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect. Immun. 52:50-55.
3. Berry AM, Yother J, Briles DE, Hansman D, Paton JC. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.
4. Gelber SE, Aguilar JL, Lewis KLT, Ratner AJ. 2008. Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J. Bacteriol. 190:3896-3903.
5. Giddings KS, Zhao J, Sims PJ, Tweten RK. 2004. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat. Struct. Mol. Biol. 11:1173-1178.
6. Wickham SE, Hotze EM, Farrand AJ, Polekhina G, Nero TL, Tomlinson S, Parker MW, Tweten RK. 2011. Mapping the intermedilysinhuman CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9. J. Biol. Chem. 286:20952-20962.
7. Johnson S, Brooks NJ, Smith RAG, Lea SM, Bubeck D. 2013. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep. 3:1369-1377.
8. Eschenbach DA. 1993. History and review of bacterial vaginosis. Am. J. Obstet. Gynecol. 169:441-445.
9. Marrazzo JM, Martin DH, Watts DH, Schulte J, Sobel JD, Hillier SL, Deal C, Fredricks DN. 2010. Bacterial vaginosis: identifying research gaps. Proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex. Transm. Dis. 37:732-744.
10. Patterson JL, Stull-Lane A, Girerd PH, Jefferson KK. 2010. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosisassociated anaerobes. Microbiology (Reading, Engl.) 156:392-399.
11. Los FCO, Randis TM, Aroian RV, Ratner AJ. 2013. Role of pore-forming toxins in bacterial infectious diseases. Microbiol. Mol. Biol. Rev. 77:173-207.
12. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG. 2006. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126:1135-1145.
13. Cassidy SKB, O'Riordan MXD. 2013. More than a pore: the cellular response to cholesterol-dependent cytolysins. Toxins (Basel) 5:618-636.
14. Idone V, Tam C, Goss JW, Toomre D, Pypaert M, Andrews NW. 2008. Repair of injured plasma membrane by rapid Ca2+-dependent endocytosis. J. Cell Biol. 180:905-914.
15. Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, Aroian RV. 2004. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc. Natl. Acad. Sci. U. S. A. 101:10995-11000.
16. Keyel PA, Loultcheva L, Roth R, Salter RD, Watkins SC, Yokoyama WM, Heuser JE. 2011. Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane. J. Cell Sci. 124:2414-2423.
17. Iliev AI, Djannatian JR, Nau R, Mitchell TJ, Wouters FS. 2007. Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin. Proc. Natl. Acad. Sci. U. S. A. 104:2897-2902.
18. Förtsch C, Hupp S, Ma J, Mitchell TJ, Maier E, Benz R, Iliev AI. 2011. Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity. Toxins (Basel) 3:43-62.
19. Hymes SR, Randis TM, Sun TY, Ratner AJ. 2013. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo. J. Infect. Dis. 207:1491-1497.
20. Fichorova RN, Rheinwald JG, Anderson DJ. 1997. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissuespecific differentiation proteins. Biol. Reprod. 57:847-855.
21. Rampersaud R, Planet PJ, Randis TM, Kulkarni R, Aguilar JL, Lehrer RI, Ratner AJ. 2011. Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners. J. Bacteriol. 193:1034-1041.
22. Jost BH, Lucas EA, Billington SJ, Ratner AJ, McGee DJ. 2011. Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum. BMC Microbiol. 11:239. doi:10.1186/1471-2180-11-239.
23. Farrand AJ, LaChapelle S, Hotze EM, Johnson AE, Tweten RK. 2010. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad. Sci. U. S. A. 107:4341-4346.
24. LaChapelle S, Tweten RK, Hotze EM. 2009. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis. J. Biol. Chem. 284:12719-12726.
25. Randis TM, Kulkarni R, Aguilar JL, Ratner AJ. 2009. Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. PLoS One 4:e5207. doi:10.1371/journal.pone.0005207.
26. Ratner AJ, Hippe KR, Aguilar JL, Bender MH, Nelson AL, Weiser JN. 2006. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J. Biol. Chem. 281:12994-12998.
27. Charras GT, Hu C-K, Coughlin M, Mitchison TJ. 2006. Reassembly of contractile actin cortex in cell blebs. J. Cell Biol. 175:477-490.
28. Tam C, Idone V, Devlin C, Fernandes MC, Flannery A, He X, Schuchman E, Tabas I, Andrews NW. 2010. Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J. Cell Biol. 189:1027-1038.
29. Giddings KS, Johnson AE, Tweten RK. 2003. Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins. Proc. Natl. Acad. Sci. U. S. A. 100:11315-11320.
30. Hotze EM, Tweten RK. 2012. Membrane assembly of the cholesteroldependent cytolysin pore complex. Biochim. Biophys. Acta 1818:1028-1038.
31. Tweten RK. 2005. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73:6199-6209.
32. Heuck AP, Moe PC, Johnson BB. 2010. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins. Subcell. Biochem. 51:551-577.
33. Rosado CJ, Kondos S, Bull Kuiper TEMJ, Law RHP, Buckle AM, Voskoboinik I, Bird PI, Trapani JA, Whisstock JC, Dunstone MA. 2008. The MACPF/CDC family of pore-forming toxins. Cell. Microbiol. 10:1765-1774.
34. Bischofberger M, Iacovache I, van der Goot FG. 2012. Pathogenic pore-forming proteins: function and host response. Cell Host Microbe 12:266-275.
35. Corrotte M, Fernandes MC, Tam C, Andrews NW. 2012. Toxin pores endocytosed during plasma membrane repair traffic into the lumen of MVBs for degradation. Traffic 13:483-494.
36. Husmann M, Beckmann E, Boller K, Kloft N, Tenzer S, Bobkiewicz W, Neukirch C, Bayley H, Bhakdi S. 2009. Elimination of a bacterial poreforming toxin by sequential endocytosis and exocytosis. FEBS Lett. 583:337-344.
37. Los FCO, Kao C-Y, Smitham J, McDonald KL, Ha C, Peixoto CA, Aroian RV. 2011. RAB-5-and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell Host Microbe 9:147-157.
38. Kao C-Y, Los FCO, Huffman DL, Wachi S, Kloft N, Husmann M, Karabrahimi V, Schwartz J-L, Bellier A, Ha C, Sagong Y, Fan H, Ghosh P, Hsieh M, Hsu C-S, Chen L, Aroian RV. 2011. Global functional analyses of cellular responses to pore-forming toxins. PLoS Pathog. 7:e1001314. doi:10.1371/journal.ppat.1001314.
39. Babiychuk EB, Monastyrskaya K, Potez S, Draeger A. 2011. Blebbing confers resistance against cell lysis. Cell Death Differ. 18:80-89.
40. Catlin BW. 1992. Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin. Microbiol. Rev. 5:213-237.
41. Harwich MD, Alves JM, Buck GA, Strauss JF, Patterson JL, Oki AT, Girerd PH, Jefferson KK. 2010. Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics 11:375. doi:10.1186/1471-2164-11-375.
42. Yeoman CJ, Yildirim S, Thomas SM, Durkin AS, Torralba M, Sutton G, Buhay CJ, Ding Y, Dugan-Rocha SP, Muzny DM, Qin X, Gibbs RA, Leigh SR, Stumpf R, White BA, Highlander SK, Nelson KE, Wilson BA. 2010. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One 5:e12411. doi:10.1371/journal.pone.0012411.
43. Fredricks DN, Fiedler TL, Marrazzo JM. 2005. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353:1899-1911.